Myomo (MYO) Change in Accured Expenses (2016 - 2025)
Myomo's (MYO) quarterly Change in Accured Expenses came in at -$1.4 million in Q3 2025, down 251.21% on a YoY basis from $904822.0 in Q3 2024, and up 30.62% quarter-over-quarter from -$2.0 million in Q2 2025.
Analysis
Myomo (MYO) Change in Accured Expenses (2016 - 2025) Analysis & Trends
Myomo (MYO) has reported Change in Accured Expenses for 10 consecutive years, with -$1.4 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Change in Accured Expenses fell 251.21% year-over-year to -$1.4 million; the trailing twelve-month figure through Sep 2025 stood at $897995.0 (down 41.84% YoY), and the FY2024 full-year result was $4.7 million, up 162.17% from the prior year.
- Change in Accured Expenses rose to -$1.4 million in Q3 2025 per MYO's latest filing, from -$2.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.8 million in Q4 2024 and bottomed at -$2.0 million in Q2 2025.
- Historically, Change in Accured Expenses has averaged $262382.1 across 5 years, with a median of $386880.0 in 2023.
- The widest YoY moves for Change in Accured Expenses: up 1555.4% in 2025, down 318.16% in 2025.
- Over 5 years, Change in Accured Expenses stood at $535997.0 in 2021, then sank by 183.53% to -$447716.0 in 2022, then climbed by 21.41% to -$351845.0 in 2023, then surged by 895.05% to $2.8 million in 2024, then plunged by 148.91% to -$1.4 million in 2025.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.4 million, -$2.0 million, and $1.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 55.00 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | -531.00 Mn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 298.00 Mn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 234.00 Mn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 123.70 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | -74.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 112.90 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Myomo | 54.96 Mn | 35.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -1.37 Mn |
| Jun 30, 2025 | -1.97 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 904,822.00 |
| Jun 30, 2024 | 903,932.00 |
| Mar 31, 2024 | 87,041.00 |
| Dec 31, 2023 | -351,845.00 |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 501,714.00 |
| Mar 31, 2023 | 386,880.00 |
| Dec 31, 2022 | -447,716.00 |
| Sep 30, 2022 | 278,415.00 |
| Jun 30, 2022 | -837,425.00 |
| Mar 31, 2022 | 294,828.00 |
| Dec 31, 2021 | 535,997.00 |
| Sep 30, 2021 | 559,312.00 |
| Jun 30, 2021 | -934,413.00 |
| Mar 31, 2021 | 952,339.00 |
| Dec 31, 2020 | 723,618.00 |